The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–
If you are a shareholder who suffered a loss, click here to participate.
On June 4, 2024, Bonitas Research published a report alleging, among other things, that there is “no evidence that Cibus’ gene-editing technology brings desirable new crops to market,” and, instead, there are “farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and distributors walking away from joint ventures and partnerships with Cibus for a variety of seed types and seed traits.”
On this news, Cibus’ stock price fell as much as 13% during intraday trading on June 4, 2024, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Cibus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
[email protected]
www.frankcruzlaw.com
